SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nymox Pharmaceutical Corp. – ‘20-F’ for 12/31/20 – ‘EX-101.CAL’

On:  Monday, 3/29/21, at 4:42pm ET   ·   For:  12/31/20   ·   Accession #:  1640334-21-680   ·   File #:  1-12033

Previous ‘20-F’:  ‘20-F’ on 3/30/20 for 12/31/19   ·   Next:  ‘20-F/A’ on 6/11/21 for 12/31/20   ·   Latest:  ‘20-F’ on 5/2/23 for 12/31/22   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/21  Nymox Pharmaceutical Corp.        20-F       12/31/20  103:4.4M                                   Pubco Reporting … Inc/FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML    684K 
                Non-Canadian Issuer                                              
 4: EX-13.A     Annual or Quarterly Report to Security Holders      HTML     24K 
 5: EX-13.B     Annual or Quarterly Report to Security Holders      HTML     24K 
 2: EX-12.A     Statement re: the Computation of Ratios             HTML     28K 
 3: EX-12.B     Statement re: the Computation of Ratios             HTML     28K 
12: R1          Cover                                               HTML     59K 
13: R2          Consolidated Statements of Comprehensive Loss       HTML     72K 
14: R3          Consolidated Statements of Financial Position       HTML     83K 
15: R4          Consolidated Statements of Financial Position       HTML     26K 
                (Parenthetical)                                                  
16: R5          Consolidated Statements of Cash Flow                HTML     85K 
17: R6          Consolidated Statements of Changes in Equity        HTML     59K 
18: R7          Business Activities and Basis of Presentation       HTML     30K 
19: R8          Going Concern Considerations                        HTML     26K 
20: R9          Significant Estimates                               HTML     25K 
21: R10         Significant Accounting Policies                     HTML     63K 
22: R11         New Accounting Standards and Interpretations        HTML     28K 
23: R12         Property and Equipment                              HTML     63K 
24: R13         Intangible Assets                                   HTML     25K 
25: R14         Accounts Payable and Accrued Liabilities            HTML     32K 
26: R15         Operating Leases and Commitments                    HTML     42K 
27: R16         Share Capital                                       HTML     33K 
28: R17         Stock Options                                       HTML     47K 
29: R18         Share Based Compensation                            HTML     30K 
30: R19         Warrants                                            HTML     43K 
31: R20         Income Taxes                                        HTML     55K 
32: R21         Earnings Per Share                                  HTML     31K 
33: R22         Financial Instruments Fair Value Disclosures        HTML     25K 
34: R23         Finance Income and Finance Costs                    HTML     34K 
35: R24         Segment Disclosures                                 HTML     34K 
36: R25         Concentrations                                      HTML     29K 
37: R26         Related Party Transactions                          HTML     34K 
38: R27         Research and Development Expenses                   HTML     33K 
39: R28         Personnel Expenses                                  HTML     31K 
40: R29         Capital Disclosures and Financial Risk              HTML     25K 
41: R30         Foreign Exchange Risk                               HTML     25K 
42: R31         Credit Risk                                         HTML     25K 
43: R32         Interest Rate Risk                                  HTML     24K 
44: R33         Liquidity Risk                                      HTML     29K 
45: R34         Subsequent Events                                   HTML     25K 
46: R35         Significant Accounting Policies (Policies)          HTML     92K 
47: R36         Significant Accounting Policies (Tables)            HTML     25K 
48: R37         New Accounting Standards and Interpretations        HTML     27K 
                (Tables)                                                         
49: R38         Property and Equipment (Tables)                     HTML     62K 
50: R39         Accounts Payable and Accrued Liabilities (Tables)   HTML     30K 
51: R40         Operating Leases and Commitments (Tables)           HTML     39K 
52: R41         Share Capital (Tables)                              HTML     30K 
53: R42         Stock Options (Tables)                              HTML     45K 
54: R43         Share Based Compensation (Tables)                   HTML     28K 
55: R44         Warrants (Tables)                                   HTML     39K 
56: R45         Income Taxes (Tables)                               HTML     50K 
57: R46         Earnings Per Share (Tables)                         HTML     28K 
58: R47         Finance Income and Finance Costs (Tables)           HTML     32K 
59: R48         Segment Disclosures (Tables)                        HTML     32K 
60: R49         Concentrations (Tables)                             HTML     27K 
61: R50         Related Party Transactions (Tables)                 HTML     28K 
62: R51         Research and Development Expenses (Tables)          HTML     31K 
63: R52         Personnel Expenses (Tables)                         HTML     29K 
64: R53         Liquidity Risk (Tables)                             HTML     27K 
65: R54         Significant Accounting Policies (Details)           HTML     31K 
66: R55         Significant Accounting Policies (Details            HTML     30K 
                Narrative)                                                       
67: R56         Property and Equipment (Details)                    HTML     48K 
68: R57         Property and Equipment (Details Narrative)          HTML     26K 
69: R58         Intangible Assets (Details Narrative)               HTML     29K 
70: R59         Accounts Payable and Accrued Liabilities (Details)  HTML     32K 
71: R60         Operating Leases and Commitments (Details)          HTML     29K 
72: R61         Operating Leases and Commitments (Details 1)        HTML     33K 
73: R62         Operating Leases and Commitment (Details            HTML     37K 
                Narrative)                                                       
74: R63         Share Capital (Details)                             HTML     26K 
75: R64         Share Capital (Details Narrative)                   HTML     35K 
76: R65         Stock Options (Details)                             HTML     48K 
77: R66         Stock Options (Details 1)                           HTML     42K 
78: R67         Stock Options (Details Narrative)                   HTML     27K 
79: R68         Share Based Compensation (Details)                  HTML     32K 
80: R69         Share Based Compensation (Details Narrative)        HTML     36K 
81: R70         Warrants (Details)                                  HTML     36K 
82: R71         Warrants (Details Narrative)                        HTML     30K 
83: R72         Income Taxes (Details)                              HTML     37K 
84: R73         Income Taxes (Details 1)                            HTML     27K 
85: R74         Income Taxes (Details 2)                            HTML     79K 
86: R75         Income Taxes (Details Narrative)                    HTML     25K 
87: R76         Earnings Per Share (Details)                        HTML     28K 
88: R77         Finance Income and Finance Costs (Details)          HTML     37K 
89: R78         Segment Disclosures (Details)                       HTML     40K 
90: R79         Concentrations (Details)                            HTML     32K 
91: R80         Related Party Transactions (Details)                HTML     34K 
92: R81         Related Party Transactions (Details Narrative)      HTML     33K 
93: R82         Research and Development Expenses (Details)         HTML     37K 
94: R83         Personnel Expenses (Details)                        HTML     31K 
95: R84         Personnel Expenses (Details Narrative)              HTML     29K 
96: R85         Capital Disclosures and Financial Risk (Details     HTML     32K 
                Narrative)                                                       
97: R86         Foreign Exchange Risk (Details Narrative)           HTML     25K 
98: R87         Credit Risk (Details Narrative)                     HTML     29K 
99: R88         Interest Rate Risk (Details Narrative)              HTML     24K 
100: R89         Liquidity Risk (Details)                            HTML     33K  
102: XML         IDEA XML File -- Filing Summary                      XML    188K  
101: EXCEL       IDEA Workbook of Financial Reports                  XLSX    106K  
 6: EX-101.INS  XBRL Instance -- nymox-20201231                      XML   1.27M 
 9: EX-101.CAL  XBRL Calculations -- nymox-20201231_cal              XML    150K 
11: EX-101.DEF  XBRL Definitions -- nymox-20201231_def               XML    385K 
 8: EX-101.LAB  XBRL Labels -- nymox-20201231_lab                    XML    773K 
10: EX-101.PRE  XBRL Presentations -- nymox-20201231_pre             XML    662K 
 7: EX-101.SCH  XBRL Schema -- nymox-20201231                        XSD    264K 
103: ZIP         XBRL Zipped Folder -- 0001640334-21-000680-xbrl      Zip    122K  


‘EX-101.CAL’   —   XBRL Calculations — nymox-20201231_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="yes" encoding="windows-1252"?>
<!-- XBRL Document Created with XBRLMaster -->
<!-- Version: 2.3.08 -->
<!-- Based on XBRL 2.1 -->
<!-- Date of creation: 03/28/2021 -->
<!-- Software architectural design and coding: Dipendra K. Singh -->
<!-- Copyright (c) 2021 I-NET Business Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://nymox.com/role/Cover" xlink:href="nymox-20201231.xsd#Cover" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="nymox-20201231.xsd#ConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConsolidatedStatementsOfFinancialPosition" xlink:href="nymox-20201231.xsd#ConsolidatedStatementsOfFinancialPosition" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical" xlink:href="nymox-20201231.xsd#ConsolidatedStatementsOfFinancialPositionParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConsolidatedStatementsOfCashFlow" xlink:href="nymox-20201231.xsd#ConsolidatedStatementsOfCashFlow" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:href="nymox-20201231.xsd#ConsolidatedStatementsOfChangesInEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/BusinessActivitiesAndBasisOfPresentation" xlink:href="nymox-20201231.xsd#BusinessActivitiesAndBasisOfPresentation" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/GoingConcernConsiderations" xlink:href="nymox-20201231.xsd#GoingConcernConsiderations" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantEstimates" xlink:href="nymox-20201231.xsd#SignificantEstimates" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPolicies" xlink:href="nymox-20201231.xsd#SignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/NewAccountingStandardsAndInterpretations" xlink:href="nymox-20201231.xsd#NewAccountingStandardsAndInterpretations" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipment" xlink:href="nymox-20201231.xsd#PropertyAndEquipment" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IntangibleAssets" xlink:href="nymox-20201231.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="nymox-20201231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/OperatingLeasesAndCommitments" xlink:href="nymox-20201231.xsd#OperatingLeasesAndCommitments" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareCapital" xlink:href="nymox-20201231.xsd#ShareCapital" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/StockOptions" xlink:href="nymox-20201231.xsd#StockOptions" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensation" xlink:href="nymox-20201231.xsd#ShareBasedCompensation" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/WARRANTS" xlink:href="nymox-20201231.xsd#WARRANTS" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxes" xlink:href="nymox-20201231.xsd#IncomeTaxes" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/EarningsPerShare" xlink:href="nymox-20201231.xsd#EarningsPerShare" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/FinancialInstrumentsFairValueDisclosures" xlink:href="nymox-20201231.xsd#FinancialInstrumentsFairValueDisclosures" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCosts" xlink:href="nymox-20201231.xsd#FinanceIncomeAndFinanceCosts" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosures" xlink:href="nymox-20201231.xsd#SegmentDisclosures" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/CONCENTRATIONS" xlink:href="nymox-20201231.xsd#CONCENTRATIONS" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactions" xlink:href="nymox-20201231.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpenses" xlink:href="nymox-20201231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PersonnelExpenses" xlink:href="nymox-20201231.xsd#PersonnelExpenses" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/CapitalDisclosuresAndFinancialRisk" xlink:href="nymox-20201231.xsd#CapitalDisclosuresAndFinancialRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ForeignExchangeRisk" xlink:href="nymox-20201231.xsd#ForeignExchangeRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/CreditRisk" xlink:href="nymox-20201231.xsd#CreditRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/InterestRateRisk" xlink:href="nymox-20201231.xsd#InterestRateRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/LiquidityRisk" xlink:href="nymox-20201231.xsd#LiquidityRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SubsequentEvents" xlink:href="nymox-20201231.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesPolicies" xlink:href="nymox-20201231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesTables" xlink:href="nymox-20201231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/NewAccountingStandardsAndInterpretationsTables" xlink:href="nymox-20201231.xsd#NewAccountingStandardsAndInterpretationsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentTables" xlink:href="nymox-20201231.xsd#PropertyAndEquipmentTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="nymox-20201231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/OperatingLeasesAndCommitmentsTables" xlink:href="nymox-20201231.xsd#OperatingLeasesAndCommitmentsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareCapitalTables" xlink:href="nymox-20201231.xsd#ShareCapitalTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/StockOptionsTables" xlink:href="nymox-20201231.xsd#StockOptionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationTables" xlink:href="nymox-20201231.xsd#ShareBasedCompensationTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/WarrantsTables" xlink:href="nymox-20201231.xsd#WarrantsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesTables" xlink:href="nymox-20201231.xsd#IncomeTaxesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/EarningsPerShareTables" xlink:href="nymox-20201231.xsd#EarningsPerShareTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCostsTables" xlink:href="nymox-20201231.xsd#FinanceIncomeAndFinanceCostsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosuresTables" xlink:href="nymox-20201231.xsd#SegmentDisclosuresTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConcentrationsTables" xlink:href="nymox-20201231.xsd#ConcentrationsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsTables" xlink:href="nymox-20201231.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="nymox-20201231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PersonnelExpensesTables" xlink:href="nymox-20201231.xsd#PersonnelExpensesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/LiquidityRiskTables" xlink:href="nymox-20201231.xsd#LiquidityRiskTables" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesDetails" xlink:href="nymox-20201231.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="nymox-20201231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentDetails" xlink:href="nymox-20201231.xsd#PropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="nymox-20201231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IntangibleAssetsDetailsNarrative" xlink:href="nymox-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="nymox-20201231.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/OperatingLeasesAndCommitmentsDetails" xlink:href="nymox-20201231.xsd#OperatingLeasesAndCommitmentsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/OperatingLeasesAndCommitmentsDetails1" xlink:href="nymox-20201231.xsd#OperatingLeasesAndCommitmentsDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/OperatingLeasesAndCommitmentDetailsNarrative" xlink:href="nymox-20201231.xsd#OperatingLeasesAndCommitmentDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareCapitalDetails" xlink:href="nymox-20201231.xsd#ShareCapitalDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareCapitalDetailsNarrative" xlink:href="nymox-20201231.xsd#ShareCapitalDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetails" xlink:href="nymox-20201231.xsd#StockOptionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetails1" xlink:href="nymox-20201231.xsd#StockOptionsDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetailsNarrative" xlink:href="nymox-20201231.xsd#StockOptionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationDetails" xlink:href="nymox-20201231.xsd#ShareBasedCompensationDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationDetailsNarrative" xlink:href="nymox-20201231.xsd#ShareBasedCompensationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/WarrantsDetails" xlink:href="nymox-20201231.xsd#WarrantsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/WarrantsDetailsNarrative" xlink:href="nymox-20201231.xsd#WarrantsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails" xlink:href="nymox-20201231.xsd#IncomeTaxesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails1" xlink:href="nymox-20201231.xsd#IncomeTaxesDetails1" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails2" xlink:href="nymox-20201231.xsd#IncomeTaxesDetails2" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetailsNarrative" xlink:href="nymox-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/EarningsPerShareDetails" xlink:href="nymox-20201231.xsd#EarningsPerShareDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCostsDetails" xlink:href="nymox-20201231.xsd#FinanceIncomeAndFinanceCostsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosuresDetails" xlink:href="nymox-20201231.xsd#SegmentDisclosuresDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ConcentrationsDetails" xlink:href="nymox-20201231.xsd#ConcentrationsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsDetails" xlink:href="nymox-20201231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="nymox-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpensesDetails" xlink:href="nymox-20201231.xsd#ResearchAndDevelopmentExpensesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PersonnelExpensesDetails" xlink:href="nymox-20201231.xsd#PersonnelExpensesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/PersonnelExpensesDetailsNarrative" xlink:href="nymox-20201231.xsd#PersonnelExpensesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:href="nymox-20201231.xsd#CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/ForeignExchangeRiskDetailsNarrative" xlink:href="nymox-20201231.xsd#ForeignExchangeRiskDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/CreditRiskDetailsNarrative" xlink:href="nymox-20201231.xsd#CreditRiskDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/InterestRateRiskDetailsNarrative" xlink:href="nymox-20201231.xsd#InterestRateRiskDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://nymox.com/role/LiquidityRiskDetails" xlink:href="nymox-20201231.xsd#LiquidityRiskDetails" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:title="000002 - Statement - Consolidated Statements of Comprehensive Loss">
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-fullRevenueFromSaleOfGoods"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullRevenueFromSaleOfGoods" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-fullResearchAndDevelopmentExpense"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" weight="-1"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_OperatingLeaseInterestExpense" xlink:label="loc_nymoxOperatingLeaseInterestExpense"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_nymoxOperatingLeaseInterestExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-fullAdjustmentsForFinanceIncome"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForFinanceIncome" xlink:type="arc" weight="1"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConsolidatedStatementsOfFinancialPosition" xlink:title="000003 - Statement - Consolidated Statements of Financial Position">
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_SecurityDeposit" xlink:label="loc_nymoxSecurityDeposit"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_nymoxSecurityDeposit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-fullInventories"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullInventories" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_CashAtBank" xlink:label="loc_nymoxCashAtBank"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_nymoxCashAtBank" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LongtermDeposits" xlink:label="loc_ifrs-fullLongtermDeposits"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullLongtermDeposits" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_OperatingLeaseRightofuseAssetNet" xlink:label="loc_nymoxOperatingLeaseRightofuseAssetNet"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_nymoxOperatingLeaseRightofuseAssetNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_OperatingLeaseLiabilityDueWithinOneYear" xlink:label="loc_nymoxOperatingLeaseLiabilityDueWithinOneYear"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_nymoxOperatingLeaseLiabilityDueWithinOneYear" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="loc_ifrs-fullOtherCurrentFinancialLiabilities"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullOtherCurrentFinancialLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_ShareCapitalSubscriptionReceivable" xlink:label="loc_nymoxShareCapitalSubscriptionReceivable"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_nymoxShareCapitalSubscriptionReceivable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities"/>
<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical" xlink:title="000004 - Statement - Consolidated Statements of Financial Position (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConsolidatedStatementsOfCashFlow" xlink:title="000005 - Statement - Consolidated Statements of Cash Flow">
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_EmployeeDepositOfOverpayment" xlink:label="loc_nymoxEmployeeDepositOfOverpayment"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_nymoxEmployeeDepositOfOverpayment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromBanks" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInDepositsFromBanks"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInDepositsFromBanks" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_AmortizationAndOthers" xlink:label="loc_nymoxAmortizationAndOthers"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_nymoxAmortizationAndOthers" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_IssuedStockForServiceFee" xlink:label="loc_nymoxIssuedStockForServiceFee"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_nymoxIssuedStockForServiceFee" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationExpense"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="nymox-20201231.xsd#nymox_RepaymentOfOperatingLeaseAndFinancingObligation" xlink:label="loc_nymoxRepaymentOfOperatingLeaseAndFinancingObligation"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_nymoxRepaymentOfOperatingLeaseAndFinancingObligation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-fullProceedsFromIssuingShares"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromIssuingShares" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:title="000006 - Statement - Consolidated Statements of Changes in Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/BusinessActivitiesAndBasisOfPresentation" xlink:title="000007 - Disclosure - BUSINESS ACTIVITIES AND BASIS OF PRESENTATION"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/GoingConcernConsiderations" xlink:title="000008 - Disclosure - GOING CONCERN CONSIDERATIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantEstimates" xlink:title="000009 - Disclosure - SIGNIFICANT ESTIMATES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPolicies" xlink:title="000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/NewAccountingStandardsAndInterpretations" xlink:title="000011 - Disclosure - NEW ACCOUNTING STANDARDS AND INTERPRETATIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipment" xlink:title="000012 - Disclosure - PROPERTY AND EQUIPMENT"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IntangibleAssets" xlink:title="000013 - Disclosure - INTANGIBLE ASSETS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/OperatingLeasesAndCommitments" xlink:title="000015 - Disclosure - OPERATING LEASES AND COMMITMENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapital" xlink:title="000016 - Disclosure - SHARE CAPITAL"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptions" xlink:title="000017 - Disclosure - STOCK OPTIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensation" xlink:title="000018 - Disclosure - SHARE BASED COMPENSATION"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WARRANTS" xlink:title="000019 - Disclosure - WARRANTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxes" xlink:title="000020 - Disclosure - INCOME TAXES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShare" xlink:title="000021 - Disclosure - EARNINGS PER SHARE"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinancialInstrumentsFairValueDisclosures" xlink:title="000022 - Disclosure - FINANCIAL INSTRUMENTS FAIR VALUE DISCLOSURES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCosts" xlink:title="000023 - Disclosure - FINANCE INCOME AND FINANCE COSTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosures" xlink:title="000024 - Disclosure - SEGMENT DISCLOSURES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CONCENTRATIONS" xlink:title="000025 - Disclosure - CONCENTRATIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactions" xlink:title="000026 - Disclosure - RELATED PARTY TRANSACTIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpenses" xlink:title="000027 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpenses" xlink:title="000028 - Disclosure - PERSONNEL EXPENSES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CapitalDisclosuresAndFinancialRisk" xlink:title="000029 - Disclosure - CAPITAL DISCLOSURES AND FINANCIAL RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ForeignExchangeRisk" xlink:title="000030 - Disclosure - FOREIGN EXCHANGE RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CreditRisk" xlink:title="000031 - Disclosure - CREDIT RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/InterestRateRisk" xlink:title="000032 - Disclosure - INTEREST RATE RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRisk" xlink:title="000033 - Disclosure - LIQUIDITY RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SubsequentEvents" xlink:title="000034 - Disclosure - SUBSEQUENT EVENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesPolicies" xlink:title="000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesTables" xlink:title="000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/NewAccountingStandardsAndInterpretationsTables" xlink:title="000037 - Disclosure - NEW ACCOUNTING STANDARDS AND INTERPRETATIONS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentTables" xlink:title="000038 - Disclosure - PROPERTY AND EQUIPMENT (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/OperatingLeasesAndCommitmentsTables" xlink:title="000040 - Disclosure - OPERATING LEASES AND COMMITMENTS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalTables" xlink:title="000041 - Disclosure - SHARE CAPITAL (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsTables" xlink:title="000042 - Disclosure - STOCK OPTIONS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationTables" xlink:title="000043 - Disclosure - SHARE BASED COMPENSATION (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsTables" xlink:title="000044 - Disclosure - WARRANTS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesTables" xlink:title="000045 - Disclosure - INCOME TAXES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShareTables" xlink:title="000046 - Disclosure - EARNINGS PER SHARE (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCostsTables" xlink:title="000047 - Disclosure - FINANCE INCOME AND FINANCE COSTS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosuresTables" xlink:title="000048 - Disclosure - SEGMENT DISCLOSURES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConcentrationsTables" xlink:title="000049 - Disclosure - CONCENTRATIONS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsTables" xlink:title="000050 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="000051 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpensesTables" xlink:title="000052 - Disclosure - PERSONNEL EXPENSES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRiskTables" xlink:title="000053 - Disclosure - LIQUIDITY RISK (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesDetails" xlink:title="000054 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="000055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentDetails" xlink:title="000056 - Disclosure - PROPERTY AND EQUIPMENT (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="000057 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IntangibleAssetsDetailsNarrative" xlink:title="000058 - Disclosure - INTANGIBLE ASSETS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000059 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/OperatingLeasesAndCommitmentsDetails" xlink:title="000060 - Disclosure - OPERATING LEASES AND COMMITMENTS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/OperatingLeasesAndCommitmentsDetails1" xlink:title="000061 - Disclosure - OPERATING LEASES AND COMMITMENTS (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/OperatingLeasesAndCommitmentDetailsNarrative" xlink:title="000062 - Disclosure - OPERATING LEASES AND COMMITMENT (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalDetails" xlink:title="000063 - Disclosure - SHARE CAPITAL (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalDetailsNarrative" xlink:title="000064 - Disclosure - SHARE CAPITAL (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetails" xlink:title="000065 - Disclosure - STOCK OPTIONS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetails1" xlink:title="000066 - Disclosure - STOCK OPTIONS (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetailsNarrative" xlink:title="000067 - Disclosure - STOCK OPTIONS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationDetails" xlink:title="000068 - Disclosure - SHARE BASED COMPENSATION (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationDetailsNarrative" xlink:title="000069 - Disclosure - SHARE BASED COMPENSATION (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsDetails" xlink:title="000070 - Disclosure - WARRANTS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsDetailsNarrative" xlink:title="000071 - Disclosure - WARRANTS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails" xlink:title="000072 - Disclosure - INCOME TAXES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails1" xlink:title="000073 - Disclosure - INCOME TAXES (Details 1)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails2" xlink:title="000074 - Disclosure - INCOME TAXES (Details 2)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetailsNarrative" xlink:title="000075 - Disclosure - INCOME TAXES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShareDetails" xlink:title="000076 - Disclosure - EARNINGS PER SHARE (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCostsDetails" xlink:title="000077 - Disclosure - FINANCE INCOME AND FINANCE COSTS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosuresDetails" xlink:title="000078 - Disclosure - SEGMENT DISCLOSURES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConcentrationsDetails" xlink:title="000079 - Disclosure - CONCENTRATIONS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsDetails" xlink:title="000080 - Disclosure - RELATED PARTY TRANSACTIONS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000081 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpensesDetails" xlink:title="000082 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpensesDetails" xlink:title="000083 - Disclosure - PERSONNEL EXPENSES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpensesDetailsNarrative" xlink:title="000084 - Disclosure - PERSONNEL EXPENSES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:title="000085 - Disclosure - CAPITAL DISCLOSURES AND FINANCIAL RISK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ForeignExchangeRiskDetailsNarrative" xlink:title="000086 - Disclosure - FOREIGN EXCHANGE RISK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CreditRiskDetailsNarrative" xlink:title="000087 - Disclosure - CREDIT RISK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/InterestRateRiskDetailsNarrative" xlink:title="000088 - Disclosure - INTEREST RATE RISK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRiskDetails" xlink:title="000089 - Disclosure - LIQUIDITY RISK (Details)"/>
</link:linkbase>


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/16  Nymox Pharmaceutical Corp.        20-F       12/31/15    8:1.2M                                   e3 Fil… Computershare/FA
 6/03/11  Nymox Pharmaceutical Corp.        20-F/A     12/31/10    7:474K                                   e3 Fil… Computershare/FA
 6/30/04  Nymox Pharmaceutical Corp.        20-F       12/31/03    7:1.1M                                   Foley & Lardner/FA
 6/27/02  Nymox Pharmaceutical Corp.        20-F       12/31/01    2:246K                                   Foley & Lardner/FA
Top
Filing Submission 0001640334-21-000680   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 5:53:39.1am ET